Alimta

Main information

  • Trade name:
  • Alimta 100 mg Powder for infusion
  • Dosage:
  • 100 mg
  • Pharmaceutical form:
  • Powder for infusion
  • Units in package:
  • Vial, glass, 10 mL Type I clear glass vial with bromobutyl rubber stopper, 100 mg
  • Class:
  • Prescription
  • Prescription type:
  • Prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Eli Lilly SA

Documents

Localization

  • Available in:
  • Alimta 100 mg Powder for infusion
    New Zealand
  • Language:
  • English

Therapeutic information

  • Therapeutic indications:
  • · ALIMTA in combination with cisplatin is indicated for initial treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. · ALIMTA as monotherapy is indicated for treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Other information

Status

  • Source:
  • Medsafe - Medicines Safety Authority - New Zealand
  • Authorization number:
  • 13307
  • Authorization date:
  • 23-10-2007
  • Last update:
  • 27-09-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

ALIMTA ®

ALIMTA ®

pemetrexeddisodium

ConsumerMedicineInformation

Whatisinthisleaflet

Thisleafletanswerssomecommon

questionsaboutALIMTA.Itdoesnot

containalltheavailableinformation.

Itdoesnottaketheplaceoftalkingto

yourdoctororpharmacist.

Theinformationinthisleafletwas

lastupdatedonthedateshownonthe

finalpage.Morerecentinformation

onthismedicinemaybeavailable.

Makesureyouspeaktoyour

pharmacist,nurseordoctortoobtain

themostuptodateinformationon

thismedicine.Youcanalso

downloadthemostuptodateleaflet

fromwww.lilly.com.au.Theupdated

leafletmaycontainimportant

informationaboutALIMTAandits

usethatyoushouldbeawareof.

Allmedicineshaverisksand

benefits.Yourdoctorhasweighed

therisksofyoutakingALIMTA

againstthebenefitsthismedicineis

expectedtohaveforyou.

Ifyouhaveanyconcernsabout

takingthismedicine,askyour

doctororpharmacist.

Keepthisleaflet.

Youmayneedtoreaditagain.

WhatALIMTAisused

for

ALIMTAisusedtotreat:

mesothelioma,ararecancerof

thelungsoftenrelatedto

exposuretoasbestos

non-smallcelllungcancer,atype

Itbelongstoagroupofmedicines

calledcytotoxicorantineoplastic

agents.Theymayalsobecalled

chemotherapymedicines.

Itaffectsenzymeswithincancercells

tokillcancercellsorpreventthem

growingandmultiplying.

Yourdoctormayhaveprescribedit

foranotherreason.

Askyourdoctorifyouhaveany

questionsaboutwhythismedicine

hasbeenprescribedforyou.

Thismedicineisavailableonlywith

adoctor'sprescription.

ALIMTAmaybeusedin

combinationwithother

chemotherapydrugs.

Beforeyouaregiven

ALIMTA

When youmustnotbegiven

it

DonottakeALIMTAifyouhave

anallergyto:

anymedicinecontaining

pemetrexeddisodium

anyoftheingredientslistedatthe

endofthisleaflet.

Someofthesymptomsofanallergic

reactionmayincludeshortnessof

breath,wheezingordifficulty

breathing;swellingoftheface,lips,

tongueorotherpartsofthebody;

rash,itchingorhivesontheskin.

Ifyouarenotsurewhetheryou

shouldbegiventhismedicine,talk

Beforeyouaregiven it

Tellyourdoctorifyouhaveor

havehadanyofthefollowing

medicalconditions:

kidneyproblems

Tellyourdoctorifyouare

pregnantorplantobecome

pregnantorarebreast-feeding.

Pregnancyandbreast-feedingshould

beavoidedduringALIMTA

treatment.Yourdoctorcandiscuss

withyoutherisksandbenefits

involved.

Thismedicineisnotrecommended

foruseinchildrenundertheageof

18years.

Safetyandeffectivenessinchildren

youngerthan18yearshavenotbeen

established.

Ifyouhavenottoldyourdoctor

aboutanyoftheabove,tell

him/herbeforeyoutakeALIMTA.

TakingPremedication

Yourdoctorshouldadviseyouto

takecertainmedicinesorvitamin

whiletakingALIMTA.Thesemay

helptominimisesideeffects.

Yourdoctorshouldadviseyouto

takeafolatesupplementora

multivitamincontainingfolate

oncedailyforatleastfivedaysin

theweekbeforeyourfirst

ALIMTAdose.Thisshouldbe

continuedthroughoutyour

therapycyclesandforatleast

threeweeksfollowingcompletion

ofALIMTAtreatment.

Yourdoctorshouldalsoadviseyou

tohaveavitaminB12injection

duringtheweekbeforeyourfirst

doseofALIMTA.AvitaminB12

ALIMTA ®

injectionshouldbegivenonce

everythreetreatmentcycles.

Yourdoctormayalsoadviseyouto

takeanoralcorticosteroidsuchas

dexamethasonetoreducethe

likelihoodandseverityofskin

rashes.

Askyourdoctorifyouhaveany

questionsaboutwhytheseother

medicineshavebeenprescribedfor

you.

Takingothermedicines

Tellyourdoctororpharmacistif

youaretakinganyother

medicines,includinganythatyou

buywithoutaprescriptionfrom

yourpharmacy,supermarketor

healthfoodshop.

Somemedicinesmaybeaffectedby

ALIMTAormayaffecthowit

works.Theseinclude:

medicinesusedtotreatarthritisor

painfrominflammationsuchas

ibuprofenorothernon-steroidal

anti-inflammatorymedicines

(NSAIDs).

Youmayneeddifferentamountsof

yourmedicinesortostoptaking

themforafewdaysoryoumayneed

totakedifferentmedicines.

Yourdoctorandpharmacisthave

moreinformationonmedicinestobe

carefulwithoravoidwhiletaking

ALIMTA.

HowALIMTAwillbe

given

Followalldirectionsgiventoyou

byyourdoctororpharmacist

carefully.

Howmuch isgiven

Yourdoctorwilldecidethedosageof

ALIMTAyoushouldtake.Thiswill

dependonyourconditionandother

Howitisgiven

ALIMTAisgivenasaninfusion

(drip)intoyourveinsovera10

minuteperiod.

Whentreatingcertaincancers,you

mayalsobegivenother

chemotherapymedicines.

Yourdoctorornursewillinject

ALIMTAforyou.

NeverinjectALIMTAyourself.

Alwaysletyourdoctorornursedo

this.

Howoften itisgiven

ALIMTAisgivenonceeverythree

weeks(1treatmentcycle).Your

doctorwilladvisehowmany

treatmentcyclesyouneed.

Beforeeachinfusionyouwillhave

samplesofyourbloodtakentocheck

thatyouhaveenoughbloodcellsto

receiveALIMTA.Yourdoctormay

decidetochangeyourdoseordelay

treatingyoudependingonyour

generalconditionandifyourblood

cellcountsaretoolow.

Overdose

AsALIMTAisgiventoyouunder

thesupervisionofyourdoctor,itis

unlikelythatyouwillhavetoo

much

However,ifyouexperienceany

sideeffectsafterbeinggiven

ALIMTA,immediatelytellyour

doctorornurseorgotothe

EmergencyDepartmentatyour

nearesthospital.

Youmayneedurgentmedical

attention.

Whileyouaretaking

ALIMTA

Thingsyoumustdo

Alwaystakeyourdailyfolate

supplementuntilyourdoctortells

Alwayscheckwithyourdoctor

thatyourvitaminB12injections

areuptodate.

Ifyouareabouttobestartedon

anynewmedicine,remindyour

doctorandpharmacistthatyou

arereceivingALIMTA.

Tellanyotherdoctors,dentistsand

pharmacistswhotreatyouthat

youarereceivingthismedicine.

Ifyouaregoingtohavesurgery,

tellthesurgeonoranaesthetistthat

youarereceivingthismedicine.

Itmayaffectothermedicinesused

duringsurgery.

Ifyoubecomepregnantwhile

receivingthismedicine,tellyour

doctorimmediately.

Ifyouareabouttohaveanyblood

tests,tellyourdoctorthatyouare

receivingthismedicine.

Keepallofyourdoctor's

appointmentssothatyourprogress

canbechecked.

Yourdoctormaydosometestsfrom

timetotimetomakesurethe

medicineisworkingandtoprevent

unwantedsideeffects.

Thingsto becarefulof

Becarefuldrivingoroperating

machineryuntilyouknowhow

ALIMTAaffectsyou.

Thismedicinemaycausetirednessor

drowsinessinsomepeople.Ifyou

haveanyofthesesymptoms,donot

drive,operatemachineryordo

anythingelsethatcouldbe

dangerous.

Sideeffects

Tellyourdoctororpharmacistas

soonaspossibleifyoudonotfeel

wellwhileyouaretaking

ALIMTA.

Thismedicineistohelppeoplewith

mesotheliomaornon-smallcelllung

ALIMTA ®

cancer,butitmayhaveunwanted

sideeffectsinsomepeople.

Allmedicinescanhavesideeffects.

Sometimestheyareserious,mostof

thetimetheyarenot.Youmayneed

medicalattentionifyougetsomeof

thesideeffects.

Donotbealarmedbythefollowing

listsofsideeffects.Youmaynot

experienceanyofthem.

Askyourdoctororpharmacistto

answeranyquestionsyoumayhave.

Tellyourdoctororpharmacistif

younoticeanyofthefollowingand

theyworryyou:

fatigue,drowsiness,fainting

feelingdehydrated

paininthestomach,upset

stomach,nausea,lossofappetite,

vomiting

diarrhoea,constipation,dark

urine

muscleweakness

skinirritation,burningor

pricklingsensation

hairloss

conjunctivitis(redanditchyeyes

withorwithoutdischargeand

crustyeyelids)

coughing,difficultybreathing,

wheezingcausedbyinflammation

ofthelung

abdominal,chest,backorleg

pain.

Additionalsideeffectswhenusedin

combinationwithother

chemotherapyagentsinclude:

tastechange

lossoffeeling

kidneyproblemswhereyoupass

littleornourine.

Theabovelistsincludethemore

commonsideeffectsofyour

medicine.Whenusedincombination

withotherchemotherapymedicine,

alsorefertotheotherproduct's

consumermedicineinformation

leafletforalistofotherpossibleside

Tellyourdoctorassoonaspossible

ifyounoticeanyofthefollowing:

feverorinfectionwitha

temperature,sweatingorother

signsofinfection

pain,redness,swellingorsoresin

yourmouth

suddensignsofallergysuchas

rash,itchingorhivesontheskin,

swellingoftheface,lipsor

tongueorotherpartsofthebody,

shortnessofbreath,wheezingor

troublebreathing

tiredness,feelingfaintor

breathless,ifyoulookpale

bleedingorbruisingmoreeasily

thannormal.

Theabovelistincludesseriousside

effectswhichmayrequiremedical

attention.

InrarecasesALIMTAcancause

inflammationofthecolon(large

bowel).Tellyourdoctorassoonas

possibleifyouexperienceanyof

thefollowingsymptoms:

diarrhoeawithbloodandmucus

stomachpain

fever.

Ifanyofthefollowinghappen,tell

yourdoctorimmediatelyorgoto

theEmergencyDepartmentat

yournearesthospital:

chestpainorfastheartbeat

bleedingfromthegums,noseor

mouth,anybleedingthatwillnot

stop,reddishorpinkishurine,

unexpectedbruising.

Theabovelistincludesveryserious

sideeffects.Youmayneedurgent

medicalattentionorhospitalisation.

Tellyourdoctororpharmacistif

younoticeanythingthatismaking

youfeelunwell.

Othersideeffectsnotlistedabove

mayalsooccurinsomepeople.

Someofthesesideeffects(for

example,abnormalbloodtests

showinglowcellcounts)canonlybe

foundwhenyourdoctordoesteststo

AfterhavingALIMTA

Storage

Thismedicinewillbestoredinthe

hospitalpharmacyorontheward.

Itwillbekeptinacooldryplace

wherethetemperaturestaysbelow

25°C.

Productdescription

Whatitlookslike

ALIMTAisawhitetooffwhite

powderandisavailableinaglass

vialcontainerwitharubberstopper.

Ingredients

ALIMTAissuppliedin500mgand

100mgvials.

The500mgvialofALIMTA

containspemetrexeddisodium

equivalentto500mgpemetrexedand

500mgofmannitol.

The100mgvialofALIMTA

containspemetrexeddisodium

equivalentto100mgpemetrexedand

106.4mgofmannitol.

Hydrochloricacidand/orsodium

hydroxidemaybeaddedtoboth

presentationstoadjustpH.

Supplier

ALIMTAissuppliedby

EliLillyAustraliaPtyLimited

112WharfRoad

WESTRYDENSW2114

Australian Registration

Number:

ALIMTA500mg,AUSTR96731

ALIMTA100mg,AUSTR146828

ThisleafletwasrevisedinMay2013.

=RegisteredTrademark

There are no news related to this product.